ACRS vs AMGN: Which Stock is Better?

Side-by-side comparison of Aclaris Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

ACRS

Aclaris Therapeutics Inc

$4.43

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricACRSAMGNWinner
Market Cap$283.86M$177.92BAMGN
P/E RatioN/A25.57AMGN
EPS (TTM)$N/A$12.92AMGN
Revenue Growth-0.2%0.1%AMGN
Gross Margin-275.7%70.1%AMGN

Analyze ACRS

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACRS or AMGN a better investment?

Comparing ACRS and AMGN: Aclaris Therapeutics Inc has a market cap of $283.86M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACRS and AMGN?

ACRS (Aclaris Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACRS or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACRS or AMGN?

AMGN has higher revenue growth at 0.1% vs -0.2% for ACRS.

Which company is more profitable: ACRS or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to -275.7% for ACRS.

Which is the larger company: ACRS or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $283.86M for ACRS.

Should I buy ACRS or AMGN in 2026?

Both ACRS and AMGN have investment merit. ACRS trades at $4.43 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACRS and AMGN stock?

Key differences: Market Cap ($283.86M vs $177.92B), P/E Ratio (N/A vs 25.6x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (-275.7% vs 70.1%).

Popular Stock Comparisons